← Research library

The First Dipeptide Mimetic of Neurotrofin-3: Design and Pharmacological Properties.

Animal research · 2022

What was studied
Cell cultures and mice
Main finding
GTS-301 activated TrkC and TrkB, protected HT-22 cells in injury assays and showed antidepressant-like activity in a mouse forced-swim experiment.

Study data at a glance

Participants or experimental model
Cell cultures and mice
Reported results
GTS-301 activated TrkC and TrkB, protected HT-22 cells in injury assays and showed antidepressant-like activity in a mouse forced-swim experiment.
Study limitations and source details

Study limitations

  • Preclinical findings do not establish human benefit or safety.
  • Abstract only. Full methods and independent replication remain unconfirmed.

Source details

Primary publication metadata and indexed abstract checked via Europe PMC; full methodological review pending.

Abstract reviewed

Sources checked

Citation

Animal / experimentalEnglish abstract

Gudasheva TA, Sazonova NM, Tarasiuk AV, Logvinov IO, Antipova TA, Nikiforov DM, Povarnina PY, Seredenin SB. The First Dipeptide Mimetic of Neurotrofin-3: Design and Pharmacological Properties. Doklady. Biochemistry and biophysics

Study source ↗ · DOI 10.1134/s1607672922040032 · Bibliography entry · Link to this summary

Related compounds

Editorial policy and evidence standards